Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2)
Research Grade Biosimilar
Human
VHH-hFc (IgG1)
3-2A2-4
Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2)
Research Grade Biosimilar
Human
IgG1, kappa
H014
Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2)
Research Grade Biosimilar
Human
IgG1, kappa
COVA1-16
Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2)
Research Grade Biosimilar
Human
IgG1, kappa
CV2-75
Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2)
Research Grade Biosimilar
Human
IgG1, kappa
6D60
Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2)
Research Grade Biosimilar
Human
IgG1, kappa
BG10-19
Middle East respiratory syndrome-related coronavirus (isolate UnitedKingdom/H123990006/2012) (MERS-CoV) (Betacoronavirus England 1)
Research Grade Biosimilar
Human
IgG1
REGN3051
SARS-CoV-2(2019-nCoV)
Research Grade Biosimilar
Human
IgG1-kappa
S2M11
SARS-CoV-2 (2019-nCoV)
Research Grade Biosimilar
Human
IgG
47D11
SARS-CoV-2 (2019-nCoV)
Research Grade Biosimilar
Human
IgG
CT P63